Is the impact of add on heart failure therapy influenced by background therapy?

Lancet Diabetes Endocrinol. 2022 Jan;10(1):3-5. doi: 10.1016/S2213-8587(21)00311-9. Epub 2021 Nov 30.

Authors

Lars Rydén¹, Giulia Ferrannini²

Affiliations

¹ Department of Medicine K2, Karolinska Institutet, Stockholm SE-171 76, Sweden. Electronic address: lars.ryden@ki.se.
² Department of Medicine K2, Karolinska Institutet, Stockholm SE-171 76, Sweden.

PMID: 34861151
DOI: 10.1016/S2213-8587(21)00311-9

No abstract available

MeSH terms

Drug Interactions
Heart Failure* / drug therapy
Humans
Treatment Outcome

Associated data

ClinicalTrials.gov/NCT03057977
ClinicalTrials.gov/NCT03036124